Microtek Medical Holdings, Inc - Post-Effective Amendment to an S-8 filing (S-8 POS)

AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON NOVEMBER 9, 2007.

REGISTRATION NO. 333-117736

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

POST-EFFECTIVE AMENDMENT NO. 1

TO FORM S-8

REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OF 1933

Microtek Medical Holdings, Inc.

(Exact name of Registrant as specified in its charter)

Georgia	58-1746149
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification Number)

13000 Deerfield Parkway, Suite 300

Alpharetta, Georgia 30004

(Address of principal executive offices, including zip code)

1999 Long-Term Incentive Plan, As Amended

(Full title of the plan)

Dan R. Lee

13000 Deerfield Parkway

Suite 300

Alpharetta, Georgia 30004

(678) 896-4400

(Name, address and telephone number of agent for service)

Copies to:

Stephen D. Fox, Esq.

Arnall Golden Gregory LLP

171 17 ^TH Street

Suite 2100

Atlanta, Georgia 30363-1031

DEREGISTRATION OF UNSOLD SECURITIES

This Post-Effective Amendment No. 1 amends the Registration Statement on Form S-8, Registration No. 333-117736 (the "Registration Statement"), of Microtek Medical Holdings, Inc. (the "Company"), which was filed with the Securities and Exchange Commission and became effective on July 29, 2004. The Registration Statement registered 2,145,000 shares of the Company's common stock, par value $0.001 per share ("Common Stock"), for sale pursuant to the 1999 Long-Term Incentive Plan, as amended.

The offering pursuant to the Registration Statement has been terminated. In accordance with an undertaking made by the Company in the Registration Statement to remove from registration, by means of a post-effective amendment, any of the securities which remain unsold at the termination of the offering, the Company hereby removes from registration the 537,900 shares of Common Stock registered, but unsold, under the Registration Statement.

PART II

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to its Registration Statement on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Atlanta, State of Georgia, on the 9th day of November, 2007.

	MICROTEK MEDICAL HOLDINGS, INC.


	By: /s/ Dan R. Lee
	Name: Dan R. Lee
	Title: Chairman, President and Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to the Registration Statement has been signed below by the following persons in the capacities indicated on the 9th day of November, 2007.

Signature		Title

/s/ Dan R. Lee		Chairman, President and Chief Executive Officer
Dan R. Lee		(Principal Executive Officer)

/s/ Roger G. Wilson*		Chief Financial Officer and Treasurer
Roger G. Wilson		(Principal, Financial and Accounting Officer)

/s/ Kenneth F. Davis*		Director
Kenneth F. Davis

/s/ Michael E. Glasscock, III*		Director
Michael E. Glasscock, III

/s/ Rosdon Hendrix*		Director
Rosdon Hendrix

/s/ Gene R. McGrevin*		Director
Gene R. McGrevin

/s/ Marc R. Sarni*		Director
Marc R. Sarni

/s/ Ronald L. Smorada*		Director
Ronald L. Smorada

By: /s/ Dan R. Lee
Dan R. Lee, as attorney-in-fact